Clay Siegall seems like the kind of guy that’s pretty interested in science. He has been all his life. He believes in the pursuit of scientific truth at all costs, whether it is concerning climate change, the science of the universe or the pursuit for a cancer cure.
His love of science is reflected in his blog. You can also see the guy really loves NFL football. His blog is full of NPR retweets concerning all sorts of science. Upon first glance, you can see that he is incredibly concerned about the environment. On March 14, 2017, he posted a story about environmental science, climate and the forecast of half the world’s Arctic sea ice. It is hard to say what his political leanings are, but it is clear that the scientific stories that he posts on his website are in contradiction to everything the Trump administration has stated about science.
Another glimpse into his beliefs is the reposting of an NPR story about how couples can navigate the Trump administration’s repeal and replacement of the Affordable Care Act. As the CEO of Seattle Genetics, you can see that he is very concerned with people losing their health care. After all, he has spent a lifetime pursuing scientific treatments and cures for cancer.
He spent the better part of the 1980s and 1990s as a cancer researcher for a variety of scientific groups. It is here that he discovered that each cancer is uniquely individual and cannot be broadly categorized. This inspired him to cofound Seattle Genetics in order to target cancer treatment more precisely. Now, Seattle Genetics is coming out with such groundbreaking cancer treatments that the private organization is often forced to wait for the government to approve of its medications. It’s moving much faster than the speed of government.
As the CEO of Seattle Genetics, Clay Siegall has moved more into the role of business administration within the cancer treatment community. He was able to raise $1.2 billion for his company since it went public in 2001. He is also now totally engrossed with every aspect of the business from research to distribution.